vs

Side-by-side financial comparison of IMMUCELL CORP (ICCC) and Intellicheck, Inc. (IDN). Click either name above to swap in a different company.

Intellicheck, Inc. is the larger business by last-quarter revenue ($6.6M vs $5.5M, roughly 1.2× IMMUCELL CORP). Intellicheck, Inc. runs the higher net margin — 23.4% vs -2.5%, a 25.9% gap on every dollar of revenue. On growth, Intellicheck, Inc. posted the faster year-over-year revenue change (11.8% vs -8.4%). Intellicheck, Inc. produced more free cash flow last quarter ($2.4M vs $-1.8M). Over the past eight quarters, Intellicheck, Inc.'s revenue compounded faster (19.1% CAGR vs 3.9%).

ImmuCell Corp is a US-based animal health biotechnology company that develops, manufactures and markets innovative products for livestock, primarily dairy cattle. Its core offerings include preventive and therapeutic solutions for common bovine health issues such as mastitis, serving agricultural producers and veterinary providers across North America.

Intellicheck, Inc. is a US-based technology company specializing in identity verification and fraud prevention solutions. It develops AI-powered tools to validate government-issued identification documents, streamline customer onboarding, and mitigate identity theft risks for clients across finance, retail, healthcare and public sector segments.

ICCC vs IDN — Head-to-Head

Bigger by revenue
IDN
IDN
1.2× larger
IDN
$6.6M
$5.5M
ICCC
Growing faster (revenue YoY)
IDN
IDN
+20.2% gap
IDN
11.8%
-8.4%
ICCC
Higher net margin
IDN
IDN
25.9% more per $
IDN
23.4%
-2.5%
ICCC
More free cash flow
IDN
IDN
$4.2M more FCF
IDN
$2.4M
$-1.8M
ICCC
Faster 2-yr revenue CAGR
IDN
IDN
Annualised
IDN
19.1%
3.9%
ICCC

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ICCC
ICCC
IDN
IDN
Revenue
$5.5M
$6.6M
Net Profit
$-139.7K
$1.6M
Gross Margin
42.9%
91.4%
Operating Margin
0.4%
22.5%
Net Margin
-2.5%
23.4%
Revenue YoY
-8.4%
11.8%
Net Profit YoY
80.1%
218.0%
EPS (diluted)
$-0.02
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICCC
ICCC
IDN
IDN
Q4 25
$6.6M
Q3 25
$5.5M
$6.0M
Q2 25
$6.4M
$5.1M
Q1 25
$8.1M
$4.9M
Q4 24
$7.8M
$5.9M
Q3 24
$6.0M
$4.7M
Q2 24
$5.5M
$4.7M
Q1 24
$7.3M
$4.7M
Net Profit
ICCC
ICCC
IDN
IDN
Q4 25
$1.6M
Q3 25
$-139.7K
$290.0K
Q2 25
$501.9K
$-251.0K
Q1 25
$1.4M
$-318.0K
Q4 24
$488.0K
Q3 24
$-701.7K
$-837.0K
Q2 24
$-1.5M
$-127.0K
Q1 24
$-437.9K
$-442.0K
Gross Margin
ICCC
ICCC
IDN
IDN
Q4 25
91.4%
Q3 25
42.9%
90.5%
Q2 25
43.7%
89.8%
Q1 25
41.6%
89.7%
Q4 24
36.5%
91.1%
Q3 24
26.3%
91.0%
Q2 24
22.5%
90.5%
Q1 24
31.6%
90.7%
Operating Margin
ICCC
ICCC
IDN
IDN
Q4 25
22.5%
Q3 25
0.4%
4.0%
Q2 25
8.8%
-5.8%
Q1 25
13.9%
-7.1%
Q4 24
8.0%
8.1%
Q3 24
-9.6%
-19.3%
Q2 24
-25.3%
-4.6%
Q1 24
-4.1%
-11.2%
Net Margin
ICCC
ICCC
IDN
IDN
Q4 25
23.4%
Q3 25
-2.5%
4.8%
Q2 25
7.8%
-4.9%
Q1 25
17.9%
-6.5%
Q4 24
8.2%
Q3 24
-11.7%
-17.8%
Q2 24
-28.0%
-2.7%
Q1 24
-6.0%
-9.4%
EPS (diluted)
ICCC
ICCC
IDN
IDN
Q4 25
$0.08
Q3 25
$-0.02
$0.01
Q2 25
$0.06
$-0.01
Q1 25
$0.16
$-0.02
Q4 24
$0.09
$0.02
Q3 24
$-0.09
$-0.04
Q2 24
$-0.20
$-0.01
Q1 24
$-0.06
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICCC
ICCC
IDN
IDN
Cash + ST InvestmentsLiquidity on hand
$3.9M
$9.7M
Total DebtLower is stronger
$9.5M
Stockholders' EquityBook value
$29.8M
$20.7M
Total Assets
$45.7M
$24.5M
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICCC
ICCC
IDN
IDN
Q4 25
$9.7M
Q3 25
$3.9M
$7.2M
Q2 25
$8.6M
Q1 25
$5.1M
Q4 24
$3.8M
$4.7M
Q3 24
$5.7M
Q2 24
$1.3M
$7.3M
Q1 24
$960.3K
$9.2M
Total Debt
ICCC
ICCC
IDN
IDN
Q4 25
Q3 25
$9.5M
Q2 25
Q1 25
$8.7M
Q4 24
$9.0M
Q3 24
$9.4M
Q2 24
$9.8M
Q1 24
$10.2M
Stockholders' Equity
ICCC
ICCC
IDN
IDN
Q4 25
$20.7M
Q3 25
$29.8M
$18.9M
Q2 25
$29.9M
$18.0M
Q1 25
$29.0M
$17.6M
Q4 24
$27.5M
$17.7M
Q3 24
$26.4M
$16.7M
Q2 24
$23.5M
$17.3M
Q1 24
$24.6M
$17.2M
Total Assets
ICCC
ICCC
IDN
IDN
Q4 25
$24.5M
Q3 25
$45.7M
$25.3M
Q2 25
$46.7M
$23.1M
Q1 25
$45.6M
$24.6M
Q4 24
$45.1M
$20.9M
Q3 24
$44.4M
$20.7M
Q2 24
$41.9M
$21.9M
Q1 24
$43.1M
$22.6M
Debt / Equity
ICCC
ICCC
IDN
IDN
Q4 25
Q3 25
0.32×
Q2 25
Q1 25
0.30×
Q4 24
0.33×
Q3 24
0.36×
Q2 24
0.42×
Q1 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICCC
ICCC
IDN
IDN
Operating Cash FlowLast quarter
$-1.2M
$2.4M
Free Cash FlowOCF − Capex
$-1.8M
$2.4M
FCF MarginFCF / Revenue
-32.3%
36.0%
Capex IntensityCapex / Revenue
10.8%
0.1%
Cash ConversionOCF / Net Profit
1.54×
TTM Free Cash FlowTrailing 4 quarters
$715.4K
$4.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICCC
ICCC
IDN
IDN
Q4 25
$2.4M
Q3 25
$-1.2M
$-1.7M
Q2 25
$1.6M
$3.1M
Q1 25
$1.6M
$750.0K
Q4 24
$-3.1K
$-1.3M
Q3 24
$-639.3K
$-1.1M
Q2 24
$581.8K
$-1.2M
Q1 24
$418.5K
$869.0K
Free Cash Flow
ICCC
ICCC
IDN
IDN
Q4 25
$2.4M
Q3 25
$-1.8M
$-1.8M
Q2 25
$1.4M
$3.1M
Q1 25
$1.2M
$741.0K
Q4 24
$-199.3K
$-1.3M
Q3 24
$-727.7K
$-1.1M
Q2 24
$471.0K
$-1.2M
Q1 24
$348.1K
$860.0K
FCF Margin
ICCC
ICCC
IDN
IDN
Q4 25
36.0%
Q3 25
-32.3%
-29.2%
Q2 25
22.4%
60.9%
Q1 25
15.4%
15.1%
Q4 24
-2.6%
-22.4%
Q3 24
-12.1%
-23.1%
Q2 24
8.6%
-25.5%
Q1 24
4.8%
18.4%
Capex Intensity
ICCC
ICCC
IDN
IDN
Q4 25
0.1%
Q3 25
10.8%
0.4%
Q2 25
2.4%
0.3%
Q1 25
4.1%
0.2%
Q4 24
2.5%
0.2%
Q3 24
1.5%
0.6%
Q2 24
2.0%
0.2%
Q1 24
1.0%
0.2%
Cash Conversion
ICCC
ICCC
IDN
IDN
Q4 25
1.54×
Q3 25
-5.99×
Q2 25
3.19×
Q1 25
1.09×
Q4 24
-2.71×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons